Role of Tyk-2 in Th9 and Th17 cells in allergic asthma.

Fiche du document

Date

11 août 2014

Type de document
Périmètre
Langue
Identifiants
Relations

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1038/srep05865

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/25109392

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/2045-2322

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_A417AA7476AB1

Licences

info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer




Citer ce document

C. Übel et al., « Role of Tyk-2 in Th9 and Th17 cells in allergic asthma. », Serveur académique Lausannois, ID : 10.1038/srep05865


Métriques


Partage / Export

Résumé 0

In a murine model of allergic asthma, we found that Tyk-2((-/-)) asthmatic mice have induced peribronchial collagen deposition, mucosal type mast cells in the lung, IRF4 and hyperproliferative lung Th2 CD4(+) effector T cells over-expressing IL-3, IL-4, IL-5, IL-10 and IL-13. We also observed increased Th9 cells expressing IL-9 and IL-10 as well as T helper cells expressing IL-6, IL-10 and IL-21 with a defect in IL-17A and IL-17F production. This T helper phenotype was accompanied by increased SOCS3 in the lung of Tyk-2 deficient asthmatic mice. Finally, in vivo treatment with rIL-17A inhibited local CD4(+)CD25(+)Foxp3(+) T regulatory cells as well as Th2 cytokines without affecting IL-9 in the lung. These results suggest a role of Tyk-2 in different subsets of T helper cells mediated by SOCS3 regulation that is relevant for the treatment of asthma, cancer and autoimmune diseases.

document thumbnail

Par les mêmes auteurs

Sur les mêmes sujets

Exporter en